Article | Age/sex | Presentation pattern | Peripheral blood count | Primary tumor site | Other metastases | Treatment | Survival |
---|---|---|---|---|---|---|---|
Yoshioka et al. [9] | 62/M | Primary | DIC | Rectum (diagnosed by autopsy) | N/A | N/A | Died after 13 days |
Sema et al. [10] | 61/M | N/A | DIC | Sigmoid | No | Supportive | Died after 2 weeks |
Lee et al. [11] | 67/M | Primary | Anemia/thrombocytopenia | Hepatic flexure | Bone | FOLFOX | Alive 18 weeks after diagnosis |
Huang et al. [12] | 79/M | Primary | DIC | Rectum | N/A | 5FU + leucovorin | Died after 83 days |
Pleyer et al. [13] | 48/M | Primary | Thrombocytopenia | N/A | Peritoneal/pleural/pericardial effusion/mediastinal lymphadenopathy | FOLFOX + bevacizumab (surgery for the primary) | Died after 5 cycles of chemotherapy |
Misawa et al. [14] | 51/M | Primary | DIC | Ascending colon | Bone | No | Died after 25 days |
Wang et al. [15] | 37/M | Primary | Anemia/thrombocytopenia | Sigmoid | Bone | FOLFOX + cetuximab | Died after 3 months |
Isozaki et al. [16] | 45/M | Primary | DIC | Descending colon | Lymph nodes | mFOLFOX | N/A |
Song and Dwyre [17] | 70/M | Primary | Anemia | Rectum | Bone | N/A | N/A |
Orgel et al. [18] | 65/F | Primary | MAHA | Sigmoid | Hepatic | FOLFOX + cetuximab | Died after 7 months |
Naito et al. [19] | 61/M | Primary | DIC | Transverse colon | Bone/lymphadenopathy | XELOX + bevacizumab | Resolution after 4 cycles of chemotherapy + resection was considered |
Nakashima et al. [20] | 65/M | Primary | DIC | Rectum | Bone | mFOLFOX + bevacizumab + surgery | Died 128 POD |
Shah et al. [8] | 58/M | Primary | DIC | Cecum | Hepatic/mediastinal lymphadenopathy | mFOLFOX + FOLFIRI + bevacizumab | Died after 6 months |
Van Banderin et al. [21] | 65/F | Primary | DIC | Sigmoid | Bone | XELOX | Died after 8 months |
Lim et al. [5] | 74/F | Recurrent | Anemia/thrombocytopenia | History of right hemicolectomy | No | No | 10 days after diagnosis |
Assi et al. [6] | |||||||
 1st case | 75/M | Recurrent | Anemia/leucopenia | Rectum | No | FOLFOX + bevacizumab | Alive after 6 months |
 2nd case | 56/M | Primary | Anemia/thrombocytopenia | Rectosigmoid | Bone | FOLFOX | Died after 6 months |
3rd case | 55/M | Primary | Anemia/thrombocytopenia | Ascending colon | Bone | FOLFOX | Died after 4 months |
Hanamura et al. [22] | 60/M | Primary | DIC | Sigmoid | Bone | mFOLFOX + CapeOx + irinotecan + pantumumab | Died after 10 months |
Takeyama et al. [23] | 65/M | Recurrent | Leucopenia/thrombocytopenia | Hx of rectal resection | Bone/lung | mFOLFOX | Died 263 days from meningeal metastasis |
Zeeneldin et al. [24] | 42/M | Primary | Anemia/thrombocytopenia | Rectum | Bone/lung/lymphadenopathy | XELOX | Died after 6 months |